Number of Founded Organizations 1
CB Rank (Person) 1,293,419

Dr. John Holtsclaw of New Jersey is the Medical Director at Camden Treatment Associates based in Camden, New Jersey. Demonstrating a commitment to patient care and community well-being, Dr. Holtsclaw actively participates in NJATOD and is deeply engaged in mobile care delivery services, presently overseeing the Opioid Overdose Prevention Project in

southern New Jersey. Dr. John Holtsclaw holds a Doctor of Medicine Degree from the University of Tennessee College of Medicine and pursued further studies at Indiana University, achieving dual Board Certification in Pediatrics and Internal Medicine. Following a successful private practice, Dr. Holtsclaw shifted his focus to treating patients grappling with addiction in new Jersey. He is a certified Addiction Medicine specialist and has served as Medical Director for several Medication-Assisted Treatment programs across New Jersey. Dr. John Holtsclaw is committed to providing high-quality healthcare services to the local community in Camden, New Jersey. and is known for his compassionate care and dedication to improving the health and well-being of his patients.

Number of Current Jobs 1
Dr. John Holtsclaw is the Medical Director at Camden Treatment Associates.
Number of News Articles 15
NewsFeb 1, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsDec 28, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsNov 26, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsNov 23, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsNov 23, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsNov 23, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsNov 23, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsNov 23, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsNov 23, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
NewsNov 22, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated